Bonus Biogroup ( (IL:BONS) ) has shared an announcement.
Bonus Biogroup Ltd. has announced the convening of a general meeting on March 20, 2025, at their Tel Aviv offices. The meeting agenda includes ratifying the reappointment of KPMG Somekh Chaikin as auditors, discussing financial statements and a Board of Directors’ report for 2023, and approving a restatement of financial statements for the third quarter of 2023 due to a new accounting standard. Shareholders can vote by proxy or electronically, with specific deadlines for each voting method.
More about Bonus Biogroup
YTD Price Performance: 75.00%
Average Trading Volume: 8,408
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $69.07M
For detailed information about BONS stock, go to TipRanks’ Stock Analysis page.